COVAX, the World Health Organization's vaccine alliance, says it is doubling the supply of COVID-19 treatments it will make available in 2021. Around 2 billion doses will be due for delivery in spring. The body, which has a facility in Geneva Switzerland, is the...
COVID-19PharmacovigilanceVaccine safety surveillance2023Background: The Global COVID Vaccine Safety (GCoVS) project was established in 2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate the rapid assessment of the safety of newly introduced vaccines. This study ...
population were vaccinated by then. Tedros made the remarks during a visit to a partly state-owned vaccine producer in South Africa on Saturday. He said the World Trade Organization's intellectual property rights agreement on patent waivers was in place for situations like the ...
The availability of various types of COVID-19 vaccines and diverse characteristics of the vaccines present a dilemma in vaccination choices, which may result in individuals refusing a particular COVID-19 vaccine offered, hence presenting a threat to immu
A COVID-19 vaccine designed to be inexpensive and easy to mass produce globally has received emergency use authorization from India’s government,
This commentary provides an overview and links to presentations of a recent virtual congress series organized by the International Society for Vaccines (ISV) focused on COVID-19 vaccines. The series provided the academic community and vaccine developers as well as the wider general public with balanc...
According to data from the United Nations Development Program's Global Dashboard for Vaccine Equity, about 67.53 percent of people in high-income countries have received at least one dose of COVID-19 vaccine as of Jan. 26, 2022. That compares with just 11.18 percent having received at least...
Providing normative information increases intentions to accept a COVID-19 vaccine Alex Moehring Avinash Collis Dean Eckles Nature Communications(2023) Views on the Nature of Science, Beliefs, Trust in the Government, and COVID-19 Pandemic Preventive Behavior among Undergraduate Students ...
Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by FDA, but has been authorized for emergency use by FDA, under an EUA to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months through 11 years of age. The emergency use of this product is on...